Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2014
Sabine Mueller, M.D., Ph.D.
Pediatric Diffuse Instrinsic Pontine Gliomas (DIPGs): Developing a Precision Medicine Approach for...
Read More
2014
Mo Motamedi, Ph.D.
The role of Sirtuins in epigenetics and genomic stability
Read More
2014
Colin P.N. Dinney, M.D. & David J. McConkey, Ph.D.
Defining the biological and clinical properties of the p53-like/luminal A subtype of...
Read More
2014
Qing Li, M.D., Ph.D.
Nras signaling in hematopoietic stem cells and leukemic stem cells
Read More
2014
Hui Li, Ph.D.
Gene Fusions in Rhabdomyosarcoma
Read More
2014
Calvin Lee, Ph.D.
Polycomb group protein control on micro-RNA expression in rhabdomyosarcoma
Read More
2014
Dineo Khabele, M.D.
Imaging Ovarian Cancer with Novel Small Molecule Radiotracers of Cyclooxygenase-1
Read More
2014
Paul J. Hergenrother, Ph.D.
PAC-1 for the Treatment of Breast Cancer
Read More
2014
Helene Furberg, Ph.D., M.D. & Vijai Joseph, Ph.D.
The role of germline genetic variation in host response and vascular toxicity...
Read More
2014
Steven Dubois, M.D.
Predictors of Response to IGF-R Inhibition in Metastatic Ewings Sarcoma
Read More
2014
John Cavanagh, Ph.D.
Developing New Cancer Chemotherapeutics: New Screening Protocols
Read More
2014
Parveen Bhatti, Ph.D.
Sleep Disruption and Oxidative Damage among Shift Workers
Read More
2014
David Cheresh, Ph.D., Razelle Kurzrock, M.D., Karen Messer, Ph.D., Hatim Husain, M.D.
Integrin avB3 as a CTC Biomarker and Therapeutic Target for Erlotinib-Resistant Lung...
Read More
2014
David J. Tweardy, M.D., Michael T. Lewis, Ph.D., Mothaffar F. Rimawi, M.D.
Oral small Molecular Stat3 Inhibitor to Treat Breast Cancer
Read More
2014
Wendy Stock, M.A., M.D., Yusuke Nakamura, M.D., Ph.D., Olatoyosi Odenike, M.D.
TOPK (T-LAK cell-originated protein Kinase): A new target for FLT3 mutated AML
Read More
2014
Michael B. Major, Ph.D., D. Neil Hayes, M.D., MPH, Gary Johnson, Ph.D.
Global Kinase Activity Profiling for Improved Patient Stratification and Response to Targeted...
Read More